default author photo

Enora Laas

PSL Research University - Institut Curie

Paris, CNRS UMR32

France

  • PSL Research University - Institut Curie

SCHOLARLY PAPERS

3

DOWNLOADS

227

TOTAL CITATIONS

1

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the UCBG- UNIRAD Trial

Downloads 134 (558,171)

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the UCBG- UNIRAD Trial

Number of pages: 39 Posted: 27 Mar 2025
Enora Laas, Anne-Sophie Hamy-Petit, Thomas Bachelot, Paul Gougis, Jérôme Lemonnier, Fabrice Andre, David Cameron, Judith M. Bliss, Sylvie Chabaud, Anne-Claire Hardy-Bessard, Magali Lacroix-Triki, Djelila Allouache, Marc Debled, Mario Campone, Laurence Venat, Paul Henri Cottu, Mathilde Martinez, Julien Grenier, Florence Dalenc, Elise Dumas, Fabien REYAL, Bernard Asselain, Frédérique Penault-Llorca, Francis Lévi and Sylvie Giacchetti
PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, Sorbonne University - Hôpital Pitié-Salpêtrière, UNICANCER, Gustave Roussy - Breast Cancer Unit, University of Edinburgh - Edinburgh Cancer Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Armorican Center for Radiotherapy, Medical Imaging, and Oncology (CARIO), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse, University of Bordeaux - Institut Bergonié, Institut de Cancerologie de l’Ouest, Hôpital Universitaire Dupuytren, École Normale Supérieure - PSL Research University - Institut Curie, Clinique Pasteur, Sainte Catherine Institute, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Université Paris Cité, PSL Research University - Institut Curie, UNICANCER, Centre Jean Perrin, Université Paris Saclay and Hopital Saint-Louis
Downloads 102 (684,532)

Abstract:

Loading...

breast cancer, endocrine therapy, everolimus, circadian rhythm, intake timing

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the Ucbg- Unirad Trial

Number of pages: 39 Posted: 17 Apr 2025
Enora Laas, Anne-Sophie Hamy-Petit, Thomas Bachelot, Paul Gougis, Jérôme Lemonnier, Fabrice Andre, David Cameron, Judith M. Bliss, Sylvie Chabaud, Anne-Claire Hardy-Bessard, Magali Lacroix-Triki, Djelila Allouache, Marc Debled, Mario Campone, Laurence Venat, Paul Henri Cottu, Mathilde Martinez, Julien Grenier, Florence Dalenc, Elise Dumas, Fabien REYAL, Bernard Asselain, Frédérique Penault-Llorca, Francis Albert Lévi and Sylvie Giacchetti
PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, Sorbonne University - Hôpital Pitié-Salpêtrière, UNICANCER, Gustave Roussy - Breast Cancer Unit, University of Edinburgh - Edinburgh Cancer Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Armorican Center for Radiotherapy, Medical Imaging, and Oncology (CARIO), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse, University of Bordeaux - Institut Bergonié, Institut de Cancerologie de l’Ouest, Hôpital Universitaire Dupuytren, École Normale Supérieure - PSL Research University - Institut Curie, Clinique Pasteur, Sainte Catherine Institute, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Université Paris Cité, PSL Research University - Institut Curie, UNICANCER, Centre Jean Perrin, University of Warwick - Cancer Chronotherapy Team and Hopital Saint-Louis
Downloads 32 (1,385,838)

Abstract:

Loading...

Breast cancer, endocrine therapy, everolimus, Circadian rhythm, intake timing

2.

Preoperative Brachytherapy of Early-Stage Cervical Cancer: A Multicenter Study by the Sfro Brachytherapy Group

Number of pages: 24 Posted: 22 May 2024
Kanta Ka, Abel Cordoba, Varela Cagetti, Renaud Schiappa, Manon Kissel, Alexandre Escande, Laurence Gonzague Casabianca, Chloe Buchalet, Sebastien Gouy, Philippe Morice, Fabrice Narducci, Carlos Martinez, Camille Jauffret, Eric Lambaudie, Yann Delpech, Enora Laas, Thomas Gaillard, Jean-Michel Hannoun-Levi, Sophie Espenel and Cyrus Chargari
Gustave Roussy, University of Lille II - Centre Oscar Lambret, Aix-Marseille University - Institut Paoli-Calmettes, Centre Antoine Lacassagne, PSL Research University - Institut Curie, University of Lille II - Centre Oscar Lambret, Aix-Marseille University - Institut Paoli-Calmettes, affiliation not provided to SSRN, Gustave Roussy, Gustave Roussy, Université de Lille - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, University of Lille II - Centre Oscar Lambret, Aix-Marseille University - Institut Paoli-Calmettes, University of Lille II - Centre Oscar Lambret, affiliation not provided to SSRN, PSL Research University - Institut Curie, PSL Research University - Institut Curie, affiliation not provided to SSRN, Gustave Roussy and Gustave Roussy
Downloads 57 (989,921)
Citation 1

Abstract:

Loading...

cervical cancer, preoperative brachytherapy, SURGERY, prognostic factors, adenocarcinoma

3.

Efficacy of Secondary Cytoreductive Surgery for Relapsed Ovarian Low-Grade Serous Carcinoma: A Multicenter Analysis from French Tmrg Network

Number of pages: 27 Posted: 21 Apr 2025
Thomas Gaillard, Thomas Gaillard, Judicael Hotton, Enora Laas, Frederic Marchal, Cécile Loaec, Pierre-Emmanuel Colombo, Gwenael Ferron, Anne-Sophie Bats, Sebastien Gouy, Claire Bonneau, Floriane Jochum, Frédéric Guyon, Florence JOLY, Christophe Pomel, Dominique Berton-Ruigaud, Navid Mokarram-Dorri, Thibault De La Motte Rouge, Isabelle-Laure Ray-Coquard and Fabrice Lecuru
École Normale Supérieure - PSL Research University - Institut CurieInstitut Curie - Breast, Gynecology and Reconstructive Surgery Department, affiliation not provided to SSRN, PSL Research University - Institut Curie, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Montpellier - Institute for Cancer Research in Montpellier, Institut Claudius Regaud, affiliation not provided to SSRN, Gustave Roussy, PSL Research University - Institut Curie, Université Paris Cité, University of Bordeaux - Institut Bergonié, Université de Caen, Centre Jean Perrin, affiliation not provided to SSRN, Aix-Marseille University - Institut Paoli-Calmettes, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department and PSL Research University - Institut Curie
Downloads 36 (1,236,159)

Abstract:

Loading...

Low-Grade Serous Ovarian Cancer, Secondary Cytoreductive Surgery, Recurrence, Progression-Free Survival, Overall Survival, Retrospective Study